Multicenter observational study on factors and outcomes associated with various methicillin-resistant Staphylococcus aureus types in children with cystic fibrosis

Annals of the American Thoracic Society

Volumn 12, Issue 6, 2015, Pages 864-871

  Muhlebach, Marianne S ^a,b   Heltshe, Sonya L ^c   Popowitch, Elena B ^b   Miller, Melissa B ^b   Thompson, Valeria ^c   Kloster, Margaret ^c   Ferkol, Thomas ^d,m   Hoover, Wynton C ^e   Schechter, Michael S ^f,h   Saiman, Lisa ^g   Weiner, Daniel J ⁱ   Quittell, Lynne ^j   Schechter, Michael ^k   Howenstine, Michelle ^l   Hoover, Wynton ^e   Muhlebach, Marianne ^b  

^a Division of Pediatric Pulmonology   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e University of Alabama at Birmingham   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Department of Medicine   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

ⁱ CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^j Och Spine at New York Presbyterian Hospitals   (United States)

^k EMORY UNIVERSITY   (United States)

^l RILEY HOSPITAL FOR CHILDREN   (United States)

^m ST LOUIS CHILDREN S HOSPITAL   (United States)

more..

Author keywords

Clinic visits; Methicillin resistant Staphylococcus aureus; Panton Valentine leukocidin; Risk factor; SCCmec type

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DEOXYRIBONUCLEASE; MACROLIDE; PANTON VALENTINE LEUKOCIDIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN; VIRULENCE FACTOR;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CLINICAL ASSESSMENT; COMMUNITY ACQUIRED INFECTION; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY; OBSERVATIONAL STUDY; PATIENT CARE; PRESCHOOL CHILD; PREVALENCE; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SCCMEC II GENE; SCCMEC IV GENE; SCHOOL CHILD; STATISTICAL ANALYSIS; UNITED STATES; CLINICAL TRIAL; COMPLICATION; GENETICS; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; LUNG FUNCTION TEST; MICROBIOLOGY; MIXED INFECTION; PSEUDOMONAS INFECTIONS; REGISTER; STAPHYLOCOCCAL INFECTIONS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; COINFECTION; CYSTIC FIBROSIS; DNA, BACTERIAL; EXOTOXINS; FEMALE; GENOTYPING TECHNIQUES; HUMANS; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REGISTRIES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; VIRULENCE FACTORS;

EID: 84942257215     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201412-596OC     Document Type: Article

References (42)

1. Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest 2009;136:1554-1560.
2. Cystic Fibrosis Foundation. Patient registry reports [accessed 2014 Dec]. Available from: http://www.cff.org/livingwithcf/qualityimprovement/patientregistryreport/.
3. Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010; 303:2386-2392.
4. Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008;178: 814-821.
5. Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chen WJ, Chang SC, Hsueh PR. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype affects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration. Clin Infect Dis 2012;55:1329-1337.
6. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001;45:1323-1336.
7. Shore AC, Coleman DC. Staphylococcal cassette chromosome mec: recent advances and new insights. Int J Med Microbiol 2013;303: 350-359.
8. Tenover FC, McAllister S, Fosheim G, McDougal LK, Carey RB, Limbago B, Lonsway D, Patel JB, Kuehnert MJ, Gorwitz R. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J Clin Microbiol 2008;46:2837-2841.
9. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Communityassociated methicillin-resistant Staphylococcus aureus. Lancet 2010;375:1557-1568.
10. Deurenberg RH, Stobberingh EE. The molecular evolution of hospitaland community-associated methicillin-resistant Staphylococcus aureus. Curr Mol Med 2009;9:100-115.
11. Lowy FD. Methicillin-resistant Staphylococcus aureus: where is it coming from and where is it going? JAMA Intern Med 2013;173: 1978-1979.
12. Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003;111:1265-1273.
13. Kuo SC, Chiang MC, Lee WS, Chen LY, Wu HS, Yu KW, Fung CP, Wang FD. Comparison of microbiological and clinical characteristics based on SCCmec typing in patients with community-onset meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia. Int J Antimicrob Agents 2011;39:22-26.
14. Klein E, Smith DL, Laxminarayan R. Community-associated methicillinresistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg Infect Dis 2009;15:1925-1930.
15. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:100-107.
16. Tseng MH, Wei BH, Lin WJ, Lu JJ, Lee SY, Wang SR, Chen SJ, Wang CC. Fatal sepsis and necrotizing pneumonia in a child due to community-acquired methicillin-resistant Staphylococcus aureus: case report and literature review. Scand J Infect Dis 2005;37: 504-507.
17. Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM Jr, Buller RS, Armstrong JR, Mardis ER, Storch GA, Cannon CL. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest 2007;131: 1718-1725.
18. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, Dorward DW, Gardner DJ, Lina G, et al. Is Panton-Valentine leukocidin the major virulence determinant in communityassociated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006;194:1761-1770.
19. Champion EA, Miller MB, Popowitch EB, Hobbs MM, Saiman L, Muhlebach MS; STAR-CF Study Team. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis. Pediatr Pulmonol 2014;49:230-237.
20. Stone A, Quittell L, Zhou J, Alba L, Bhat M, DeCelie-Germana J, Rajan S, Bonitz L, Welter JJ, Dozor AJ, et al. Staphylococcus aureus nasal colonization among pediatric cystic fibrosis patients and their household contacts. Pediatr Infect Dis J 2009;28:895-899.
21. Glikman D, Siegel JD, David MZ, Okoro NM, Boyle-Vavra S, Dowell ML, Daum RS. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S. aureus. Chest 2008;133:1381-1387.
22. Goodrich JS, Sutton-Shields TN, Kerr A, Wedd JP, Miller MB, Gilligan PH. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol 2009;47:1231-1233.
23. Al-Zubeidi D, Hogan PG, Boyle M, Burnham CA, Fritz SA. Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis. Pediatr Infect Dis J 2014;33:549-553.
24. Muhlebach MS, Miller M, LaVange LM, Mayhew G, Goodrich JS, Miller MB. Treatment intensity and characteristics of MRSA infection in CF. J Cyst Fibros 2011;10:201-206.
25. Heltshe SL, Saiman L, Popowitch EB, Miller MB, Kloster M, Thompson V, Ferkol TW, Hoover WC, Schechter MS, Muhlebach MS. Outcomes and treatment of chronic methicillin-resistant Staphylococcus aureus differs by staphylococcal cassette chromosome mec (SCCmec) type in children with cystic fibrosis. J Pediatr Infect Dis Soc 2014:1-7.
26. Miller MB, Gilligan PH. Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol 2003;41:4009-4015.
27. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:2155-2161.
28. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Jr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993;15: 75-88.
29. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
30. Flegal KM, Wei R, Ogden C. Weight-for-stature compared with body mass index-for-age growth charts for the United States from the Centers for Disease Control and Prevention. Am J Clin Nutr 2002;75: 761-766.
31. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. CDC growth charts: United States. Adv Data 2000;314:1-27.
32. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003;2:29-34.
33. Centers for Disease Control and Prevention. ABCs report: methicillinresistant Staphylococcus aureus, 2011 [Emerging Infections Program Network] [accessed 2014 Dec]. Available from: http://www.cdc.gov/abcs/reports-findings/survreports/mrsa11.html.
34. Sun L, Klein EY, Laxminarayan R. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis 2012;55:687-694.
35. Robicsek A, Beaumont JL, Thomson RB Jr, Govindarajan G, Peterson LR. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009;30:623-632.
36. Robicsek A, Beaumont JL, Wright MO, Thomson RB Jr, Kaul KL, Peterson LR. Electronic prediction rules for methicillin-resistant Staphylococcus aureus colonization. Infect Control Hosp Epidemiol 2011;32:9-19.
37. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997;100:E2.
38. Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, Rock MJ, Splaingard M. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 1998;26:81-88.
39. Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J 2012;40:227-238.
40. Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, Regelmann WE; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol 2007;42:513-518.
41. Taccetti G, Neri AS, Festini F, Galici V, Cocchi P, Campana S. Methicillin resistant Staphylococcus aureus in cystic fibrosis. Pediatr Pulmonol 2008;43:309, author reply 310.
42. Muhlebach MS, Popwitch E, Miller MB, Peng A, LaVange L, Saiman L; STAR-CF Study Team. Risk factors for MRSA subtypes in CF. Pediatr Pulmonol 2012;33(Suppl):304S.